-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Interest Expense history and change rate from 2019 to Q3 2025.
- Autolus Therapeutics plc Interest Expense for the quarter ending 30 Sep 2025 was $10.5M, a 1.55% decline year-over-year.
- Autolus Therapeutics plc Interest Expense for the twelve months ending 30 Sep 2025 was -$17M, a 124% decline year-over-year.
- Autolus Therapeutics plc annual Interest Expense for 2024 was $9.29M, a 79.4% decline from 2023.
- Autolus Therapeutics plc annual Interest Expense for 2023 was $45.1M, a 406% increase from 2022.
- Autolus Therapeutics plc annual Interest Expense for 2022 was $8.91M, a 706% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)